Annette North - 15 Jun 2021 Form 4 Insider Report for Turning Point Therapeutics, Inc.

Role
EVP, General Counsel & Secty.
Signature
/s/ Annette North
Issuer symbol
N/A
Transactions as of
15 Jun 2021
Net transactions value
-$900,433
Form type
4
Filing time
16 Jun 2021, 17:16:10 UTC
Previous filing
07 May 2021
Next filing
31 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TPTX Common Stock Options Exercise $255,000 +15,000 +121% $17.00 27,365 15 Jun 2021 Direct F1
transaction TPTX Common Stock Sale $430,276 -5,666 -21% $75.94 21,699 15 Jun 2021 Direct F1, F2
transaction TPTX Common Stock Sale $208,899 -2,700 -12% $77.37 18,999 15 Jun 2021 Direct F1, F3
transaction TPTX Common Stock Sale $516,258 -6,634 -35% $77.82 12,365 15 Jun 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPTX Stock Option (right to buy) Options Exercise $0 -15,000 -8.8% $0.000000 154,609 15 Jun 2021 Common Stock 15,000 $17.00 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020.
F2 The weighted average sale price for the transaction reported was $75.94, and the range of prices were between $75.49 and $76.35. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
F3 The weighted average sale price for the transaction reported was $77.37, and the range of prices were between $76.575 and $77.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
F4 The weighted average sale price for the transaction reported was $77.82, and the range of prices were between $77.59 and $78.21. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
F5 One-fourth of the option vested on April 15, 2020. Thereafter, 1/48th of the Option vests on a monthly basis over 36 months until the option becomes fully vested.